Colposcopes Selected for Screening Programme in Turkey

DySIS Medical Ltd (Edinburgh) has signed a significant contract with medical technology distributor, ITEM Medical Technologies as part of the national cervical screening programme in Turkey. The Turkish Ministry of Health aim to install the company’s colposcope instruments in every City hospital in the country and ITEM Medical Technologies has purchased an initial instalment of 75 instruments to begin the roll-out during 2016. 

Zafer Yazici, Managing Director of ITEM Medical Technologies, said: “Cervical cancer screening in Turkey is a vital component of women’s healthcare, delivered through approximately 1,000 screening centres.  The advantages offered by the DySIS Colposcope were proven in the clinical evaluation that was performed and are strongly appreciated by gynaecologists.”

The colposcopes measure and produce mapping of the cervical epithelium, which assists the clinician with evaluation, selection of biopsy sites, or whether other treatment is needed. Alastair Atkinson CEO of DySIS said; “This contract builds on the strong adoption of our products in the UK, US and Middle Eastern markets where over 80,000 DySIS examinations have now been undertaken. We continue to receive very positive feedback from consultants and we know our technology is saving women’s lives. DySIS is proving itself as the new standard of care for cervical cancer prevention.”

The instrument is now installed within 70 centres within selected US states and is available in the UK, northern Europe and the United Arab Emirates.